You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. Biphase Extended Release Tablet Formulation for Nerve Agent Pretreatment

    SBC: Zymeron Corporation            Topic: CBD181004

    Nerve agents exert their toxic effect by binding to and inactivating enzyme acetylcholinesterase, a key enzymatic regulator of cholinergic neurotransmission. The binding becomes irreversible after a varying amount of time with nerve agents and this aging process limits the treatment window of oxime reactivators. To enhance the current antidote treatment of nerve agent autoinjectors, a pyridostigmi ...

    SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
  2. Efficient Materials for Optical Cryocoolers

    SBC: ThermoDynamic Films LLC            Topic: CBD171001

    This Phase-II SBIR proposal directly addresses the need to improve the size, weight and power, SWaP, of optical cryocoolers. In particular, the proposers will work toward increasing the efficiency of optical cryocoolers by incorporating cooling materials that require less input laser power to achieve a given heat lift. The new cooling materials will be high-purity crystals doped with active rare-e ...

    SBIR Phase II 2019 Department of DefenseOffice for Chemical and Biological Defense
  3. A Next Generation, High-Precision, Field Drug Detection System

    SBC: SensoDX II, LLC            Topic: A16AT008

    The synthetic opioids fentanyl and carfentanil pose an imminent national security threat, given the ease with which they can be obtained, their low lethal doses, and their potential for weaponized use. The purpose of this agreement is to adapt SensoDx’s high-performance miniaturized diagnostics platform based on a programmable bio-nano-chip, with embedded artificial intelligence, to enable U.S. ...

    SBIR Phase II 2019 Department of DefenseOffice for Chemical and Biological Defense
  4. A High-Throughput Blood Esterase Panel Assay

    SBC: AGAVE BIOSYSTEMS INC.            Topic: CBD10108

    Organophosphorus chemical warfare nerve agents (OP-CWA) are attractive to terrorist groups and rogue states as an inexpensive and accessible technology for chemical warfare. OP-CWA and organophosphate pesticides cause severe neurological symptoms and death by inhibiting the enzyme acetylcholinesterase (AChE); the resulting excess acetylcholine accumulates and overstimulates the human or animal bo ...

    SBIR Phase I 2010 Department of DefenseOffice for Chemical and Biological Defense
  5. Ultra High-Speed Spectroradiometry for Contamination Reconnaissance and Surveillance

    SBC: SEMIOTIC ENGINEERING ASSOC. LLC            Topic: CBD09107

    We propose to develop and demonstrate the prototype for a novel technology to be used as a ultra-high-performance, ultra-high-speed spectrometry engine at the heart of Thermal Luminescence systems for standoff detection of surface contaminants. The proposed system will be able to detect transient thermal events in the fundamental vibrational fingerprint region of chemical warfare agents and of mos ...

    SBIR Phase II 2010 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government